These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

330 related articles for article (PubMed ID: 19725908)

  • 1. Advances in antifungal prophylaxis and empiric therapy in patients with hematologic malignancies.
    Murali S; Langston A
    Transpl Infect Dis; 2009 Dec; 11(6):480-90. PubMed ID: 19725908
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluating prophylaxis of invasive fungal infections in patients with haematologic malignancies.
    Maertens J
    Eur J Haematol; 2007 Apr; 78(4):275-82. PubMed ID: 17241370
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluating the role of prophylaxis in the management of invasive fungal infections in patients with hematologic malignancy.
    Cornely OA; Aversa F; Cook P; Jones B; Michallet M; Shea T; Vallejo C
    Eur J Haematol; 2011 Oct; 87(4):289-301. PubMed ID: 21752098
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antifungal therapy strategies in hematopoietic stem-cell transplant recipients: early treatment options for improving outcomes.
    Chandrasekar P; Ljungman PT
    Transplantation; 2008 Jul; 86(2):183-91. PubMed ID: 18645475
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Approaches to the management of invasive fungal infections in hematologic malignancy and hematopoietic cell transplantation.
    Michallet M; Ito JI
    J Clin Oncol; 2009 Jul; 27(20):3398-409. PubMed ID: 19487382
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevention and early treatment of invasive fungal infection in patients with cancer and neutropenia and in stem cell transplant recipients in the era of newer broad-spectrum antifungal agents and diagnostic adjuncts.
    Segal BH; Almyroudis NG; Battiwalla M; Herbrecht R; Perfect JR; Walsh TJ; Wingard JR
    Clin Infect Dis; 2007 Feb; 44(3):402-9. PubMed ID: 17205448
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fungal colonization and invasive fungal infections following allogeneic BMT using metronidazole, ciprofloxacin and fluconazole or ciprofloxacin and fluconazole as intestinal decontamination.
    Trenschel R; Peceny R; Runde V; Elmaagacli A; Dermoumi H; Heintschel von Heinegg E; Müller KD; Schaefer UW; Beelen DW
    Bone Marrow Transplant; 2000 Nov; 26(9):993-7. PubMed ID: 11100279
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New strategies of antifungal therapy in hematopoietic stem cell transplant recipients and patients with hematological malignancies.
    Leather HL; Wingard JR
    Blood Rev; 2006 Sep; 20(5):267-87. PubMed ID: 16781028
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antifungal treatment strategies in high risk patients.
    Rüping MJ; Vehreschild JJ; Cornely OA
    Mycoses; 2008 Sep; 51 Suppl 2():46-51. PubMed ID: 18721331
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidemiology of invasive fungal infection.
    Castón-Osorio JJ; Rivero A; Torre-Cisneros J
    Int J Antimicrob Agents; 2008 Nov; 32 Suppl 2():S103-9. PubMed ID: 19013332
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of fluconazole prophylaxis for prevention of invasive fungal infection in extremely low birth weight infants.
    Aziz M; Patel AL; Losavio J; Iyengar A; Berven M; Schloemer N; Jakubowicz A; Mathai T; McAuley JB
    Pediatr Infect Dis J; 2010 Apr; 29(4):352-6. PubMed ID: 19934791
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Galactomannan and computed tomography-based preemptive antifungal therapy in neutropenic patients at high risk for invasive fungal infection: a prospective feasibility study.
    Maertens J; Theunissen K; Verhoef G; Verschakelen J; Lagrou K; Verbeken E; Wilmer A; Verhaegen J; Boogaerts M; Van Eldere J
    Clin Infect Dis; 2005 Nov; 41(9):1242-50. PubMed ID: 16206097
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical issues regarding relapsing aspergillosis and the efficacy of secondary antifungal prophylaxis in patients with hematological malignancies.
    Sipsas NV; Kontoyiannis DP
    Clin Infect Dis; 2006 Jun; 42(11):1584-91. PubMed ID: 16652316
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antifungal prophylaxis and treatment in patients with hematological malignancies.
    Hwang YY; Liang R
    Expert Rev Anti Infect Ther; 2010 Apr; 8(4):397-404. PubMed ID: 20377335
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Invasive fungal infections: epidemiology and analysis of antifungal prescriptions in onco-haematology.
    des Champs-Bro B; Leroy-Cotteau A; Mazingue F; Pasquier F; François N; Corm S; Lemaitre L; Poulain D; Yakoub-Agha I; Alfandari S; Sendid B
    J Clin Pharm Ther; 2011 Apr; 36(2):152-60. PubMed ID: 21366643
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Itraconazole prevents invasive fungal infections in neutropenic patients treated for hematologic malignancies: evidence from a meta-analysis of 3,597 patients.
    Glasmacher A; Prentice A; Gorschlüter M; Engelhart S; Hahn C; Djulbegovic B; Schmidt-Wolf IG
    J Clin Oncol; 2003 Dec; 21(24):4615-26. PubMed ID: 14673051
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A multicentre pharmacoepidemiological study of therapeutic practices in invasive fungal infections in France during 1998-1999.
    Lortholary O; Charlemagne A; Bastides F; Chevalier P; Datry A; Gonzalves MF; Michel G; Tilleul P; Veber B; Herbrecht R
    J Antimicrob Chemother; 2004 Aug; 54(2):456-64. PubMed ID: 15231769
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hematopoietic SCT in patients with a history of invasive fungal infection.
    Zhang P; Song A; Wang Z; Feng S; Qiu L; Han M
    Bone Marrow Transplant; 2009 Apr; 43(7):533-7. PubMed ID: 19104496
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The place for itraconazole in treatment.
    Maertens J; Boogaerts M
    J Antimicrob Chemother; 2005 Sep; 56 Suppl 1():i33-i38. PubMed ID: 16120632
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nosocomial fungal infections: epidemiology, infection control, and prevention.
    Alangaden GJ
    Infect Dis Clin North Am; 2011 Mar; 25(1):201-25. PubMed ID: 21316001
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.